Back to STATE STREET CORP STATE STREET CORP

SRPTSRPT
Showing 8 of 11 quarters

Position history for STATE STREET CORPSTATE STREET CORP's holdings in SAREPTA THERAPEUTICS INC

STATE STREET CORP holds 8.9M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $160.2M as of 2026-Q2. The position was increased (+34.8% shares). SRPT represents 0.0% of STATE STREET CORP's portfolio.

Current Value

$160.2M

Current Shares

8.9M

Total Value Change

-$373.2M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
8.9M
+34.8%
$160.2M0.0%$17.97
39
2026-Q1
Increased
6.6M
+0.2%
$143.9M0.0%$15.87
30
2025-Q4
Increased
6.6M
+24.4%
$142M0.0%$21.49
37
2025-Q3
Increased
5.3M
+13.0%
$102.2M0.0%$18.82
34
2025-Q2
Increased
4.7M
+15.4%
$80.3M0.0%$17.11
34
2025-Q1
Decreased
4.1M
-0.0%
$259.6M0.0%$70.41
0
2024-Q4
Decreased
4.1M
-4.7%
$494.9M0.0%$121.19
0
2024-Q3
Increased
4.3M
+3.1%
$533.4M0.0%$124.53
32

Other major holders of SRPT: BNP PARIBAS FINANCIAL MARKETS, BlackRock Finance, Inc., Janus Henderson Group Ltd., BlackRock, Inc., Capital Research Global Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used